Dr. Chen has 20 years of extensive industry experience in drug discovery and development, personalized medicine, and new technology development with a strong track record of success in corporate and business development, R&D and commercialization. She has worked for global pharma companies including Merck, Roche and BioMarin to lead various licensing, M&A and alliance management activities ranging from biologics, small molecules, vaccines to gene therapy. Dr. Chen received her Ph.D. in Biochemistry from the University of Washington where she did her graduate research at the Fred Hutchinson Cancer Research Center, did her postdoctoral work at UCSF, and received bioinformatics training at Stanford University.